Abstract
Kidney cells of animals including human and marine invertebrates contain high amount of the protein denaturant, urea. Methylamine osmolytes are generally believed to offset the harmful effects of urea on proteins in vitro and in vivo. In this study we have investigated the possibility of glycine to counteract the effects of urea on three proteins by measuring thermodynamic stability, ΔGD o and functional activity parameters (Km and kcat). We discovered that glycine does not counteract the effects of urea in terms of both protein stability and functional activity. We also observed that the glycine alone is compatible with enzymes function and increases protein stability in terms of Tm (midpoint of thermal denaturation) to a great extent. Our study indicates that a most probable reason for the absence of a stabilizing osmolyte, glycine in the urea-rich cells is due to the fact that this osmolyte is non-protective to macromolecules against the hostile effects of urea, and hence is not chosen by evolutionary selection pressure.
Keywords: Urea stress, stabilizing osmolytes, counteracting osmolytes, protein stability, protein function, Kidney cells, thermodynamic stability, functional activity, glycine, urea-rich cells
Protein & Peptide Letters
Title:Why is Glycine not a Part of the Osmoticum in the Urea-rich Cells?
Volume: 20 Issue: 1
Author(s): Sheeza Khan, Zehra Bano, Laishram R. Singh, Md. Imtaiyaz Hassan, Asimul Islam and Faizan Ahmad
Affiliation:
Keywords: Urea stress, stabilizing osmolytes, counteracting osmolytes, protein stability, protein function, Kidney cells, thermodynamic stability, functional activity, glycine, urea-rich cells
Abstract: Kidney cells of animals including human and marine invertebrates contain high amount of the protein denaturant, urea. Methylamine osmolytes are generally believed to offset the harmful effects of urea on proteins in vitro and in vivo. In this study we have investigated the possibility of glycine to counteract the effects of urea on three proteins by measuring thermodynamic stability, ΔGD o and functional activity parameters (Km and kcat). We discovered that glycine does not counteract the effects of urea in terms of both protein stability and functional activity. We also observed that the glycine alone is compatible with enzymes function and increases protein stability in terms of Tm (midpoint of thermal denaturation) to a great extent. Our study indicates that a most probable reason for the absence of a stabilizing osmolyte, glycine in the urea-rich cells is due to the fact that this osmolyte is non-protective to macromolecules against the hostile effects of urea, and hence is not chosen by evolutionary selection pressure.
Export Options
About this article
Cite this article as:
Khan Sheeza, Bano Zehra, R. Singh Laishram, Imtaiyaz Hassan Md., Islam Asimul and Ahmad Faizan, Why is Glycine not a Part of the Osmoticum in the Urea-rich Cells?, Protein & Peptide Letters 2013; 20 (1) . https://dx.doi.org/10.2174/0929866511307010061
DOI https://dx.doi.org/10.2174/0929866511307010061 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structural Insight Into the Crucial Role of Ligand Chirality in the Activation of PPARs by Crystallographic Methods
Current Topics in Medicinal Chemistry Coronavirus Disease COVID-19: A New Threat to Public Health
Current Topics in Medicinal Chemistry Editorial: Multi-Target in Computer-Aided Drug Design Studies
Current Drug Targets Synthesis and Antitumour Activity of the Primin (2-methoxy-6-n-pentyl-1,4-benzoquinone) and Analogues
Medicinal Chemistry Virtual Screening, Molecular Docking and <i>In silico</i> ADME-Tox Analysis for Identification of Potential Main Protease (Mpro) Enzyme Inhibitors
Anti-Infective Agents Benzodiazepine Scaffold as Drug-like Molecular Simplification of FR235222: A Chemical Tool for Exploring HDAC Inhibition
Current Topics in Medicinal Chemistry Evaluation of Drug Transporter Interactions in Drug Discovery and Development
Combinatorial Chemistry & High Throughput Screening Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors
Current Drug Targets Quality Evaluation of Semen Oroxyli through Simultaneous Quantification of 13 Components by High Performance Liquid Chromatography
Current Pharmaceutical Analysis Preliminary Anti-Coxsackie Activity of Novel 1-[4-(5,6-dimethyl(H)- 1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas
Medicinal Chemistry Biomarkers and Osteosarcoma and IGF
Recent Patents on Biomarkers Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update
Current Neuropharmacology Star Graphs of Protein Sequences and Proteome Mass Spectra in Cancer Prediction
Current Proteomics Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patient with Hodgkin's Lymphoma History from North of Iran
Infectious Disorders - Drug Targets Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Current Clinical Pharmacology Novel N-mustard-benzimidazoles/benzothiazoles Hybrids, Synthesis and Anticancer Evaluation
Anti-Cancer Agents in Medicinal Chemistry Targeting the Bombesin/Gastrin-Releasing Peptide Receptor to Treat Sepsis
Recent Patents on Anti-Infective Drug Discovery Recent Development of Anticancer Therapeutics Targeting Akt
Recent Patents on Anti-Cancer Drug Discovery